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Spain takes over EU Council 
Presidency
tive on Patients’ Rights in Cross-bor-
der Healthcare and on the Commis-
sion’s proposals that make up the 
pharmaceutical package. 
In the area of food, the Presidency will 
pay particular attention to the Com-
mission’s proposals for a Regulation 
on the provision of food information 
to consumers and for a Regulation 
on novel food. Issues surrounding 
healthy eating and the fight against 
obesity will also be promoted. 
Finally, Spain will be seeking a suc-
cessful conclusion to the revision of 
the Pet Regulation and will aim to 
make progress on the safety of con-
sumer products.
On  January 200, Spain will take 
over the rotating Presidency of the 
Council of the European Union for 
the first half of the year.
With the entry into force of the Lis-
bon Treaty and the appointment of 
the new Commission, the Spanish 
Presidency will be taking place at a 
challenging time. While the main fo-
cus of the Presidency will be on the 
Lisbon Treaty and on an exit strategy 
from the financial crisis, Spain is also 
expected to take a strong interest in 
the area of health, food and consum-
ers.  
Concerning health, the Presidency 
will focus on reducing inequalities 
in health, on organ donation and 
transplantation and on eHealth. 
High-level conferences will be or-
ganised on all of these topics. Spain 
will also seek an agreement on the 
Commission’s proposal for a Direc-
For further information please see:
http://www.eutrio.es/en/presidencia/
Parliamentary hearing of 
Commissioner-Designate Dalli
to assess his abilities, particularly re-
garding issues covering his portfo-
lio. The parliament’s President and 
political group leaders will examine 
the results of the hearing. The debate 
and vote on the new Commission is 
expected to take place at an extraor-
dinary plenary session on 26 January. 
The hearing will be webstreamed on 
the Parliament’s website.
The parliamentary hearing of the 
Commissioner-Designate for Health 
and Consumer Policy, John Dalli, is to 
take place on 4 January at 3.00hrs 
under the lead of the Committee 
on the Environment, Public Health 
and Food Safety, with MEPs from 
the Internal Market and Consumer 
Protection and Agriculture and Rural 
Development Committees also at-
tending.
He will answer questions from MEPs 
For further information please see:
http://www.europarl.europa.eu/
2EMEA first weekly pandemic 
pharmacovigilance update
The European Medicines Agency (EMEA) 
has published on 3 December 2009 the 
first in a series of weekly pandemic phar-
macovigilance updates. 
These weekly bulletins will provide in-
formation on adverse reactions reported 
after the use of centrally authorised pan-
demic influenza vaccines and antivirals 
in the European Union, and complement 
the information the Agency has been 
publishing regularly on the development 
and approval of medicines for use during 
the pandemic. 
This information will support European 
institutions and Member States in their 
communications, and provide an addi-
tional resource when recommending the 
use of vaccines and antiviral treatments. 
The information on adverse reactions in 
the update comes from EudraVigilance, 
the central European database on ad-
verse reactions, managed by the Agency. 
It is based on reports from Member States 
and marketing authorisation holders. 
The weekly update also provides an es-
timate of how many doses of pandemic 
vaccines and antivirals have been admin-
istered in the European Union, and other 
information that helps put adverse reac-
tion reports in context.
The first update is available at:
http://www.emea.europa.eu/pdfs/
influenza/7846809en.pdf
For further information, please see:
http://www.emea.europa.eu
In brief
The text of the staff working paper can be found at:
http://ec.europa.eu/food/food/biosafety/salmonella/
antimicrobial_resistance.pdf 
For further information please see:
http://ec.europa.eu/food/food/biosafety/salmonella/
index_en.htm 
Commission paper tackles anti-
microbial resistance
trol/eradication of zoonoses, animal 
health and welfare, research activi-
ties, etc.
In the area of human medicine the 
paper points out that the Commis-
sion has funded several European 
monitoring projects that provided 
valuable and comparable data on 
the burden of disease and resist-
ance across Europe. In the field of 
food safety and veterinary medicine 
the use of antimicrobial veterinary 
products is prohibited by Commu-
nity legislation as a specific method 
to control salmonella in poultry and 
tuberculosis in cattle.
In the area of risk management for 
human medicine, the Commission 
welcomes reflections on the adop-
tion of strategies and action plans 
and on the establishment of inter-
sectorial coordinating mechanisms 
in all Member States. As to zoonoses 
control, reflections are welcome on 
ways to ensure the prudent use of 
antimicrobials in animal husbandry 
and on targeted interventions that 
would concern rules on the absence 
of resistant zoonotic agents in food.
In terms of monitoring activities in 
human medicine, the paper notes 
that thought could be given to the 
improvement of the surveillance 
system for AMR and of access to data 
and information.
The paper also deals with commu-
nication issues and notes that ideas 
would be welcome on how to fur-
ther educate the general public on 
AMR and on how to improve the 
awareness, education and training 
of health professionals in human 
and veterinary medicine.
The European Commission has re-
cently presented a staff working pa-
per that aims to be the basis of dis-
cussion on the ways to better tackle 
the problem of anti-microbial resis-
tance (AMR). The Commission’s doc-
ument provides an overview of the 
activities already undertaken by the 
European Union to address the AMR 
problem and identifies areas where 
further reflection could help the ef-
forts to come up with solutions.
Antimicrobials are essential as medi-
cines for human and animal health 
welfare and as disinfectants, anti-
septics and hygiene products. Since 
their discovery they have substan-
tially decreased the threat posed by 
various infectious diseases.
However, over the years microbes 
have evolved and have become re-
sistant to some of the antimicrobial 
medicines. Microbial resistance is 
now most evident in hospital-ac-
quired infections, respiratory tract 
infections, meningitis, diarrhoeal 
diseases and sexually transmit-
ted infections. Resistant microbes 
or resistance determinants may be 
transferred from animals to humans 
via the food chain or through direct 
contact.
Since the 990s, when AMR was 
recognised as a serious threat to 
public health, the Commission has 
launched different initiatives and 
has developed tools to monitor the 
effect of these actions. In June 2008 
the Health Council adopted conclu-
sions on AMR, calling the Commis-
sion to promote mutual cooperation 
between all Directorates General and 
concerned Agencies and to facilitate 
cooperation between the Member 
States on aspects of AMR.
This working paper outlines now the 
EU actions in terms of monitoring 
AMR and highlights the complexity 
of AMR, linked to public health, con-
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International Day of People with 
Disability
On 3 December, like every year, the In-
ternational Day of People with Disability 
(IDPwD) was celebrated worldwide, rec-
ognising the achievements and contribu-
tions of people with disability.
International Day of People with Disabili-
ty (IDPwD) is a United Nations sanctioned 
day that aims to promote an understand-
ing of people with disability and encour-
age support for their dignity, rights and 
well-being.
IDPwD brings together people with dis-
ability and the general community and 
aims to:
• showcase the skills, abilities, contribu-
tions and achievements of people with 
disability;
• promote a positive image of people with 
disability;
• involve people with disability and the 
broader community in activities to cel-
ebrate and raise awareness of IDPwD.
For further information, please see:
http://www.idpwd.com.au/index.asp
Health Programme: new complete 
project database
A database is now available providing all 
the projects co-funded by the Commis-
sion under the first and second Health 
Programme.  
This includes information about projects, 
conferences and operating grants funded 
through calls for proposals in the years 
from 2003 to 2008. 
The database is available at:
http://ec.europa.eu/eahc/projects/data-
base.html
In brief
For further information, please see:
http://ec.europa.eu/food/animal/diseases/eradica-
tion/legisl_en.htm 
Eradication, monitoring and 
control of animal diseases
salmonella, for the monitoring and 
eradication of TSEs and for avian in-
fluenza surveillance. These approved 
programmes receive financial contri-
butions from the EU.
For 200, 224 eradication, control 
and monitoring programmes for ani-
mal diseases and zoonoses, for which 
Member States wish to receive a fi-
nancial contribution from the Com-
munity, have been approved.
The European Commission has ad-
opted a financial package of €275 
million to support programmes to 
eradicate, control and monitor ani-
mal diseases in 200. The 224 annual 
or multi-annual programmes which 
were selected for EU funding will 
tackle animal diseases that impact 
both human and animal health. The 
large EU contribution towards these 
programmes reflects the high level 
of importance attached to disease 
eradication measures, for the pro-
tection of both animal and public 
health.
Each year the Commission approves 
programmes for the eradication 
and monitoring of animal diseases, 
for the control of zoonoses such as 
Maclaran to provide hinge cover 
safety kits for European consumers
After a meeting held in Brussels on 
03 December 2009 with CEO of firm 
Maclaren US Farzad Rastegar, EU 
Consumer Commissioner Meglena 
Kuneva welcomed the decision by 
Maclaren to provide all European 
consumers with hinge cover safety 
kits for pushchair buggies, on re-
quest. From 200, all new pushchairs 
will have hinge covers as a standard 
accessory.
“There can be no compromise on 
safety. The statement from Maclaren 
responds to the concerns of many 
anxious parents across Europe, who 
have quite rightly been asking ques-
tions in recent weeks. This decision 
by Maclaren will give consumers 
across Europe the peace of mind and 
high safety standards they deserve”, 
Commissioner Kuneva said.
On November 9 2009, the U.S. Con-
sumer Product Safety Commission, 
in cooperation with the firm Ma-
claren, had announced a voluntary 
corrective action. The announce-
ment from the CPC stated that the 
stroller’s hinge mechanism poses a 
fingertip amputation and laceration 
risk to the child when the consumer 
is unfolding/opening the stroller. 
The action involved all Maclaren sin-
gle and double umbrella strollers. 
Nearly one million Maclaren push-
chairs were “recalled” in the US. 
Consumers should immediately stop 
using these recalled strollers and 
contact Maclaren USA to receive a 
free repair kit.
In a statement, Maclaren Europe Lim-
ited said its products had been as-
sessed and were safe. It added: “We 
wish to reassure our customers that 
they should continue to use their ex-
isting Maclaren buggies since they 
are safe when opened and closed 
correctly”.
The letter from Maclaren to Commissioner Kuneva 
announcing the decision is available at:
http://ec.europa.eu/consumers/safety/docs/ma-
claren_decision_en.pdf
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EC tops a billion Euros invested in 
the fight against AIDS
Not too far from World AIDS Day, 
the European Commission can an-
nounce that it has invested over 
one billion Euros in the fight against 
AIDS, Tuberculosis and Malaria. As 
a founding member of the Global 
Fund to Fight AIDS, Tuberculosis and 
Malaria, the European Commission 
has to date pledged €,072.5 mil-
lion covering the period 2002-200 
and has recently made new policy 
commitments to do more, better, 
together.
According to the latest figures, new 
HIV infections have been reduced by 
7% over the past eight years and 
the most progress is seen in sub-Sa-
haran Africa. However, worldwide 
the number of people living with 
HIV now reaches 33 million, with the 
fastest spread of the epidemic oc-
curring on the threshold of the Eu-
ropean Union, in the neighbouring 
countries of Eastern Europe.
Since the beginning of the epidemic, 
almost 60 million people have been 
infected with HIV and 25 million 
people have died of AIDS related 
causes.
Although important progress has 
been achieved in preventing new 
HIV infections and in lowering the 
annual number of AIDS-related 
deaths, AIDS continues to be a ma-
jor global health priority. In 2008, 2.7 
million people became newly infect-
ed, and 2 million people died from 
AIDS-related causes.
The epidemic appears to have sta-
bilized in most regions, although 
prevalence continues to increase in 
Eastern Europe and Central Asia and 
in other parts of Asia, due to a high 
rate of new infections. Sub-Saharan 
Africa remains the most heavily af-
fected region, accounting for 7% of 
all new HIV infections in 2008.
European Commission Action:
- As the world’s largest donor, the EU 
has collectively provided the major-
ity of the significant increase in re-
cent years of international financing 
earmarked for HIV/AIDS;
- EU contributions to the Global Fund 
to Fight HIV/AIDS, Tuberculosis and 
Malaria have almost quadrupled, 
from $403 million in 2003 to $,546 
million, representing around 55% 
of world contributions in the years 
2004-2008;
- The EU Member States and the Eu-
ropean Commission have a common 
programme for action and decided 
together to call for stronger, more 
effective and more concerted ef-
forts through External Action (2007-
20);
- The Commission is increas-
ingly channelling its funds avail-
able through budget support to 
strengthen health systems, as one 
of the main ways to confront AIDS. 
This new instrument is thought to 
be particularly beneficial for health 
systems, providing longer-term and 
predictable financing;
- Budget support has increased from 
€,425 million for 2002-2006 to €2, 
57 million for 2007-20;
- The Commission has also adopted 
a new Communication (26 October 
2009) on combating HIV/AIDS in the 
European Union and neighbouring 
countries for 2009 -203, with the 
view of addressing the unfortunate 
trend of increasing infections in Eu-
rope. It focuses in particular on the 
promotion of prevention and on the 
implementation of measures target-
ing most at risk groups and particu-
lar geographical areas mostly affect-
ed by HIV/AIDS.
Commission launches the online 
vote on the new EU organic logo
In July 200 a new EU logo for organic 
products will be introduced throughout 
the European Union. Contrary to the 
existing EU organic logo, which can be 
used voluntarily, the use of the new logo 
will be compulsory for all pre-packaged 
organic products that originate in the 
27 Member States.
The new logo will indicate to European 
consumers that the organic product 
has achieved a specified level of quality 
which is standard throughout the entire 
EU. The logo ensures that the products it 
appears on are organic – from the farm 
to the fork.
All EU design or art students are invited 
to submit their most innovative designs 
to the competition for the new organic 
logo. Participants must be registered at 
an academy, university or college in one 
of the 27 EU Member States. The entries 
must be submitted by 25 June 2009.
A jury of leading design professionals 
and organic farming experts will make 
the initial shortlist of entries, which will 
then be showcased on this website. 
Through an online vote, the European 
public will then choose their favourite 
logo.
Contributing to the European organic 
movement is just one great reason to 
vote for the new EU Organic Logo. Sup-
porters of organic farming believe in 
sustainable agricultural practices that 
benefit the earth and the life forms on 
it. Along with promoting environmental 
quality for generations to come, organic 
food is simply good for nature and good 
for consumers.
By voting for your favourite logo, you 
appreciate the work of over 3400 de-
sign students from throughout the EU 
Member States and can make your voice 
heard in Europe. The choice is yours!
For further information, please see:
http://ec.europa.eu/agriculture/organ-
ic/logo/voting/voting_en.htm
In brief
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For further information, please see:
http://ec.europa.eu/health/ph_threats/com/aids/
aids_en.htm
